Summary:
If you are taking Baclofen for your spasticity (unusual "tightness", stiffness, or "pull" of muscles) due to Multiple Sclerosis (MS) you are invited to participate in a nationwide clinical research study evaluating a new extended release investigational drug.
You may qualify to be a part of the study if you are:
- At least 18 years of age
- Currently taking Baclofen IR ranging from 30 to 60 mg/day.
Participants may receive financial compensation for their time.